Trust Management Rho Net Worth & Insider Trades

Trust Management Rho Vanda Pharmaceuticals Inc

As of November 17, 2006

What is Trust Management Rho's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's Trust Management Rho is estimated to be about $31.87M . Trust Management Rho owns about 1,862,692 units of Vanda Pharmaceuticals Inc common stock. In the last 8 months at Vanda Pharmaceuticals Inc, Trust Management Rho has sold an estimated value of $8.25M worth.

What is Trust Management Rho's Past Insider Trading?

Trust Management Rho's largest sale order was 540,000 units , worth over $8.09M on November 17, 2006. In total, Trust Management Rho has made about 3 transactions over 8 months of their time at Vanda Pharmaceuticals Inc. Trust Management Rho usually trades in November, with the busiest year in 2006.

RHO VENTURES IV LP, RHO VENTURES IV QP LP, KG BETEILIGUNGS CO GMBH VENTURES RHO IV, GMBH VERWALTUNGS PARTNERS CAPITAL RHO, RHO MANAGEMENT VENTURES IV LLC, RHO CAPITAL PARTNERS INC, JOSHUA RUCH, HABIB KAIROUZ, MARK LESCHLY, TRUST MANAGEMENT RHO

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Trust Management Rho's' Mailing Address?

  • Mailing address is C/o Rho Capital Partners, Inc. 152 W. 57th Street, 23rd Floor New York NY 10019 NY

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on August 23, 2022 by Joakim Wijkstrom who sold 3,605 units worth $37.01K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $296.09M and bought an estimated value of $28.25M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1